SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-049125
Filing Date
2017-09-21
Accepted
2017-09-21 19:44:25
Documents
2
Period of Report
2017-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 v475601_form3.html 3  
1 FORM 3 v475601_form3.xml 3 6634
2 EXHIBIT 24 v475601_ex24.htm EX-24 7411
  Complete submission text file 0001144204-17-049125.txt   15699
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 171096565